Robert N. Raju

Oncology
3080 Ackerman Blvd Ste 100
Dayton, OH 45429

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications

A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer.

A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer.

Journal: International journal of oncology
Published: April 03, 2014

A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies.

A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies.

Journal: BMC cancer
Published: August 22, 2012

Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.

Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.

Journal: PloS one
Published: October 31, 2011
Showing 1-3 of 3

Last Updated: 09/26/2026